Title: AMEND S e n ate Bill No. 522 House Bill No. 502*
Official Title: AMEND S e n ate Bill No. 522 House Bill No. 502*
Number of Sections: 3
Source: versions - Amendment HA0026
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
House Insurance 1
Amendment No. 1 to HB0502
Kumar
Signature of Sponsor
by deleting all language after the enacting clause and substituting:

Section 2:
SECTION 1. Tennessee Code Annotated, Title 71, Chapter 5, Part 1, is amended by
adding the following as a new section:
(a) As used in this section:
(1) "Bureau" means the bureau of TennCare;
(2) "Enrollee" means an individual enrolled in TennCare;
(3) "Kleefstra syndrome" means a rare genetic disorder resulting from a
mutation in the euchromatic histone methyltransferase 1 (EHMT1) gene or a
deletion of a region of chromosome 9 that includes the EHMT1 gene that affects
multiple organs and functions of the body, including the face, brain, heart, and
kidneys, and that is characterized by features, including, but not limited to:
(A) Developmental delay;
(B) Intellectual disability;
(C) Distinctive facial features;
(D) Speech and hearing disorders;
(E) Seizures;
(F) Gastrointestinal disorders;
(G) Respiratory infections;
(H) Autism;
(I) Obesity; and
(J) Organ defects.
HA0026
003665
- 1 -
(b) The bureau may provide coverage and benefits on behalf of an enrollee for
the diagnosis, including genetic testing, and treatment of Kleefstra syndrome in the
same manner and to the same extent that the bureau provides coverage for autism
spectrum disorder, Trisomy 21 or Down syndrome, and other similar or related genetic
disorders, when determined to be medically necessary pursuant to ยง 71-5-144.
(c) Coverage and benefits under subsection (b) may include early intervention
and promoting improvements to the enrollee's quality of life and development throughout
the life of the enrollee through:
(1) Appropriate modalities of therapy;
(2) Appropriate medications; and
(3) Other interventive programs, education, treatments, clothing, devices,
and equipment.
(d) The director of TennCare may apply for a federal waiver as the director
deems necessary to effectuate this section.

Section 3:
SECTION 2. This act takes effect July 1, 2025, the public welfare requiring it.
- 2 - 003665
[DELETED:  a HS]
[DELETED:  -0]


================================================================================

Raw Text:
House Insurance 1
Amendment No. 1 to HB0502
Kumar
Signature of Sponsor
AMEND S e n ate Bill No. 522 House Bill No. 502*
by deleting all language after the enacting clause and substituting:
SECTION 1. Tennessee Code Annotated, Title 71, Chapter 5, Part 1, is amended by
adding the following as a new section:
(a) As used in this section:
(1) "Bureau" means the bureau of TennCare;
(2) "Enrollee" means an individual enrolled in TennCare;
(3) "Kleefstra syndrome" means a rare genetic disorder resulting from a
mutation in the euchromatic histone methyltransferase 1 (EHMT1) gene or a
deletion of a region of chromosome 9 that includes the EHMT1 gene that affects
multiple organs and functions of the body, including the face, brain, heart, and
kidneys, and that is characterized by features, including, but not limited to:
(A) Developmental delay;
(B) Intellectual disability;
(C) Distinctive facial features;
(D) Speech and hearing disorders;
(E) Seizures;
(F) Gastrointestinal disorders;
(G) Respiratory infections;
(H) Autism;
(I) Obesity; and
(J) Organ defects.
HA0026
003665
- 1 -

(b) The bureau may provide coverage and benefits on behalf of an enrollee for
the diagnosis, including genetic testing, and treatment of Kleefstra syndrome in the
same manner and to the same extent that the bureau provides coverage for autism
spectrum disorder, Trisomy 21 or Down syndrome, and other similar or related genetic
disorders, when determined to be medically necessary pursuant to ยง 71-5-144.
(c) Coverage and benefits under subsection (b) may include early intervention
and promoting improvements to the enrollee's quality of life and development throughout
the life of the enrollee through:
(1) Appropriate modalities of therapy;
(2) Appropriate medications; and
(3) Other interventive programs, education, treatments, clothing, devices,
and equipment.
(d) The director of TennCare may apply for a federal waiver as the director
deems necessary to effectuate this section.
SECTION 2. This act takes effect July 1, 2025, the public welfare requiring it.
- 2 - 003665

[DELETED:  a HS]
[DELETED:  -0]